Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Xialei ZhengJunmi LuShaojun XiangPu ZouHao ChenJing LiuCheng ZengYuhu HePublished in: Acta diabetologica (2024)
Increased LECT2 levels were significantly and independently associated with the presence and severity of MetS, indicating that LECT2 could be used as a novel biomarker and clinical predictor of MetS.